Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1B-cell Tumors 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × efavirenz × Clear all
NCT00964171 2025-08-28

PANTER

Institut Bergonié

Phase 2 Completed
19 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05560360 2023-02-02

A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
20 enrolled
Lymphoid

B-cell Tumors

NCT00964002 2022-05-16

FAVE

Institut Bergonié

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed
25 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00799136 2013-09-12

CATCH

Ontario Clinical Oncology Group (OCOG)

Phase 2 Completed
6 enrolled
LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡